Article

When worlds converge: How Most-Favored-Nation policy and International Reference Pricing reshape global market access interdependencies

  • Erika Wissinger

    Erika Wissinger

  • headshot

    David Ringger, PHD

  • Casper pardekooper

    Casper Paardekooper

  • Diane Smith headshot

    Diane Smith

This article was originally published on ISPOR

Global drug pricing decisions do not happen in isolation

This article explores how most favored nation policies and international reference pricing are reshaping global market access by linking pricing, reimbursement, and launch decisions across markets. It highlights why manufacturers need a more coordinated strategy to anticipate downstream effects on pricing, access, and commercialization. 

Click below to read the full article today.

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.
abstract

Related resources

Webinar

The first Joint Clinical Assessment is here: What market access teams should learn now

Guide

The essential guide to drug commercialization

Webinar

The transformative potential of AI in HEOR and market access